BIOTECH HOLDRS TRU DEP RCPT REP 20 BIOTECH IND (NYSEMKT:BBH)

CAPS Rating: 3 out of 5

Exchange Traded Funds

Recs

2
Player Avatar AOverlord (< 20) Submitted: 3/30/2013 9:53:15 PM : Outperform Start Price: $65.22 BBH Score: +18.77

It is weighted toward proven performs, like Amgen and Celgene, in the biotech space.

Featured Broker Partners


Advertisement